Clinical trial
Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation
NCT00186914 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186914 |
|---|---|
| Title | Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation |
| Official title | Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation: A Phase I Study |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | Drexel University Wayne State University |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteodysplasia |
| Intervention type | Biological |
| Interventions | Marrow stromal cell infusion |
| Enrollment | 8 |
| Start date | Jul 1, 1999 |
| Primary completion | Nov 1, 2001 |
| Completion | Jan 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 4, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: